| The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts Experts in Chronic Myeloid Leukemia Blood, The Journal of the American Society of Hematology 121 (22), 4439-4442, 2013 | 656 | 2013 |
| Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting K Tsukasaki, O Hermine, A Bazarbachi, L Ratner, JC Ramos, ... Journal of Clinical Oncology 27 (3), 453-459, 2009 | 596 | 2009 |
| 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ... The Lancet Oncology 20 (10), e566-e581, 2019 | 457 | 2019 |
| Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration ZF Bashshur, A Bazarbachi, A Schakal, ZA Haddad, CP El Haibi, ... American journal of ophthalmology 142 (1), 1-9, 2006 | 438 | 2006 |
| Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood … M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ... Bone marrow transplantation 51 (7), 906-912, 2016 | 435 | 2016 |
| Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study B Yamout, R Hourani, H Salti, W Barada, T El-Hajj, A Al-Kutoubi, ... Journal of neuroimmunology 227 (1-2), 185-189, 2010 | 416 | 2010 |
| Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes A Bazarbachi, Y Plumelle, J Carlos Ramos, P Tortevoye, Z Otrock, ... Journal of Clinical Oncology 28 (27), 4177-4183, 2010 | 397 | 2010 |
| Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation … M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ... Bone marrow transplantation 50 (6), 781-789, 2015 | 396 | 2015 |
| Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa O Hermine, D Bouscary, A Gessain, P Turlure, V Leblond, N Franck, ... New England Journal of Medicine 332 (26), 1749-1751, 1995 | 305 | 1995 |
| PML protein expression in hematopoietic and acute promyelocytic leukemia cells MT Daniel, M Koken, O Romagne, S Barbey, A Bazarbachi, M Stadler, ... Blood 82 (6), 1858-1867, 1993 | 300 | 1993 |
| Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation M Mohty, K Hübel, N Kröger, M Aljurf, J Apperley, GW Basak, ... Bone marrow transplantation 49 (7), 865-872, 2014 | 232 | 2014 |
| Arsenic Trioxide and Interferon- Synergize to Induce Cell Cycle Arrest and Apoptosis in Human T-Cell Lymphotropic Virus Type I–Transformed Cells A Bazarbachi, ME El-Sabban, R Nasr, F Quignon, C Awaraji, J Kersual, ... Blood, The Journal of the American Society of Hematology 93 (1), 278-283, 1999 | 213 | 1999 |
| Revised adult T-cell leukemia-lymphoma international consensus meeting report LB Cook, S Fuji, O Hermine, A Bazarbachi, JC Ramos, L Ratner, ... Journal of Clinical Oncology 37 (8), 677-687, 2019 | 212 | 2019 |
| Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow … AJ Kansagra, NV Frey, M Bar, TW Laetsch, PA Carpenter, BN Savani, ... Bone marrow transplantation 54 (11), 1868-1880, 2019 | 206* | 2019 |
| 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 D Farge, C Frere, JM Connors, AA Khorana, A Kakkar, C Ay, A Muñoz, ... The Lancet Oncology 23 (7), e334-e347, 2022 | 205 | 2022 |
| Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL) G Kchour, M Tarhini, MM Kooshyar, H El Hajj, E Wattel, M Mahmoudi, ... Blood, The Journal of the American Society of Hematology 113 (26), 6528-6532, 2009 | 203 | 2009 |
| How I treat adult T-cell leukemia/lymphoma A Bazarbachi, F Suarez, P Fields, O Hermine Blood, The Journal of the American Society of Hematology 118 (7), 1736-1745, 2011 | 200 | 2011 |
| High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey H Rafatpanah, MR Hedayati-Moghaddam, F Fathimoghadam, ... Journal of Clinical Virology 52 (3), 172-176, 2011 | 192 | 2011 |
| FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions AI Antar, ZK Otrock, E Jabbour, M Mohty, A Bazarbachi Leukemia 34 (3), 682-696, 2020 | 187 | 2020 |
| Arsenic-interferon-α–triggered apoptosis in HTLV-I transformed cells is associated with Tax down-regulation and reversal of NF-κB activation ME El-Sabban, R Nasr, G Dbaibo, O Hermine, N Abboushi, F Quignon, ... Blood, The Journal of the American Society of Hematology 96 (8), 2849-2855, 2000 | 180 | 2000 |
Rihab NasrFaculty of Medicine, American University of Beirut在 aub.edu.lb 的电子邮件经过验证
